COVIRAN launches 2nd production line as delta cases surge
Yusef Jalali
PressTV, Tehran
After passing all the clinical trials, COVIRAN launched its first production line three months ago, and now has inaugurated the second line, which will more than quadruple the output capacity to roughly 15 million doses per month.
With US sanctions casting their shadow on the import of vaccines into Iran, the inoculation program has been slow in the country.
The delta variant has now swept across Iran, killing at least 400 people every day. COVIRAN says it is speeding up its efforts to produce as many jabs as possible to stem the tide of delta, as they claim their vaccine can terminate the new variant.
So far, COVIRAN has produced and administered 7 million doses. The biotech firm says it will launch a third production facility which will add 10 million more doses each month, boosting the overall output to 25 million
Given a monthly domestic demand of less than 15 million, COVIRAN says the extra doses will be exported to other countries.
COVIRAN developers say their vaccine has so far covered 35 percent of the entire vaccination program in the country. They hope with the launching of the second production line, the government will no longer need to rely on foreign jabs to inoculate its citizens.
IAEA adopts anti-Iran resolution tabled by E3
Iran's president urges Pope to help end Israel's onslaught in Gaza
Israeli forces storm West Bank’s Jenin again, target civilians
Diplomat discourages recourse to pressure, intimidation, confrontation against Iran
UN: 2024 deadliest year for aid workers amid genocide in Gaza
Gaza health official warns of hospital shutdowns within 48 hours
Israel kills 5 more paramedics in southern Lebanon: Health ministry
Iran to launch ‘new, advanced’ centrifuges in response to IAEA resolution: AEOI
Yemen fires hypersonic missile at Israeli airbase
VIDEO | New Delhi chokes under toxic smog as air quality remains at hazardous levels
VIDEO | Press TV's news headlines
PressTV NEWSLETTER
now
This makes it easy to access the Press TV website
